Centessa Pharmaceuticals shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Centessa Pharmaceuticals (CNTA) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Centessa Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Centessa Pharmaceuticals held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Centessa Pharmaceuticals by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $6.0M | 248k | 24.25 |
| 2025-03-31 | $6.2M | 432k | 14.38 |
| 2024-12-31 | $2.9M | 176k | 16.75 |
| 2024-09-30 | $209k | 13k | 15.99 |
| 2024-03-31 | $622k | 55k | 11.30 |
| 2023-12-31 | $197k | 25k | 7.96 |
| 2023-09-30 | $69k | 11k | 6.47 |
| 2023-06-30 | $66k | 11k | 6.19 |
| 2023-03-31 | $42k | 11k | 3.85 |
| 2022-12-31 | $47k | 15k | 3.10 |
| 2022-06-30 | $81k | 17k | 4.90 |